VCAM1 and Cognitive impairment: To this end, VCAM-1 is higher in patients with AD compared to healthy age-matched controls [27] while in initially cognitively healthy adults it was shown to associate with cumulative incidence of cognitive impairment over a 10-year period, independently of age, education, and cardiovascular risk factors [28].